Thomas Thum
Works:
- SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation
- MicroRNAs bei COVID-19: kleine Moleküle mit großem Potenzial?
- Macrophage-based therapeutic approaches for cardiovascular diseases
- A pilot study for risk stratification of ventricular tachyarrhythmia in hypertrophic cardiomyopathy with routine echocardiography parameters